Ardent Health, Inc. (NYSE:ARDT) Stock Rated “Hold” by Wall Street Analysts

Ardent Health, Inc. (NYSE:ARDT – Get Free Report) has earned a consensus recommendation of “Hold” from the fourteen brokerages that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and seven have given a buy rating to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $14.86.

ARDT has been the subject of a number of research analyst reports. Royal Bank Of Canada raised their price target on Ardent Health from $13.00 to $18.00 and gave the stock an “outperform” rating in a research note on Friday, November 6th. Bank of America boosted their price objective on shares of Ardent Health from $12.00 to $14.00 and gave the company an “underperform” rating in a research report on Friday. Weiss Ratings upgraded shares of Ardent Health from a “sell (d+)” rating to a “hold (c)” rating in a report on Monday, November 9th. Stephens raised their target price on shares of Ardent Health from $13.00 to $21.00 and gave the stock an “overweight” rating in a research report on Friday, November 6th. Finally, Guggenheim raised their target price on shares of Ardent Health from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th.

View Our Latest Analysis on ARDT

Hedge Funds Weigh In On Ardent Health

A number of institutional investors have recently bought and sold shares of the stock. Wedge Capital Management L L P NC raised its stake in Ardent Health by 212.3% during the second quarter. Wedge Capital Management L L P NC now owns 327,242 shares of the company’s stock valued at $3,220,000 after buying an additional 222,447 shares during the last quarter. Ieq Capital LLC bought a new stake in Ardent Health in the second quarter worth $907,000. Bank of New York Mellon Corp bought a new stake in Ardent Health in the second quarter worth $2,377,000. Hsbc Holdings PLC purchased a new stake in shares of Ardent Health in the second quarter worth $543,000. Finally, BlackRock Inc. purchased a new stake in shares of Ardent Health in the second quarter worth $21,415,000.

Ardent Health Trading Up 0.4%

NYSE ARDT traded up $0.07 during trading on Friday, hitting $17.75. 779,496 shares of the company’s stock traded hands, compared to its average volume of 780,413. The stock has a fifty day moving average of $12.14 and a two-hundred day moving average of $10.33. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.13 and a quick ratio of 2.03. Ardent Health has a 12-month low of $7.71 and a 12-month high of $18.57. The firm has a market cap of $2.50 billion, a P/E ratio of 17.24, a PEG ratio of 3.20 and a beta of 0.58.

Ardent Health (NYSE:ARDT – Get Free Report) last issued its earnings results on Wednesday, November 4th. The company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.08. The firm had revenue of $1.62 billion for the quarter, compared to analysts’ expectations of $1.60 billion. Ardent Health had a net margin of 2.27% and a return on equity of 8.41%. As a group, sell-side analysts expect that Ardent Health will post 1.05 EPS for the current year.

Ardent Health Company Profile

(Get Free Report)

Ardent Health is a U.S. healthcare provider that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency services, surgery, and specialty and primary care through affiliated clinics and medical groups. The company serves communities in several states, including New Mexico, Oklahoma, and Texas. Its regional health systems include Lovelace Health System, Hillcrest HealthCare System, and UT Health East Texas. Ardent Health was formerly known as Ardent Health Services and became a publicly traded company in 2023.

Featured Articles

Analyst Recommendations for Ardent Health (NYSE:ARDT)

Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.